MIDAS Catalog

MIDAS

Created by National Institute of Allergy and Infectious Disease, Centers for Disease Prevention and Control and National Cancer Institute
Description:

The COVID-19 Seroprevalence Studies Hub, known as COVID-19 SeroHub, is an online dashboard intended to help researchers and policymakers monitor studies of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence in the United States. These types of studies use blood tests to identify the proportion of people in the population who possess antibodies to SARS-CoV-2. Studies included to date have been identified via literature search and review of NIH portfolios.

Preview:
https://episphere.github.io/serohub/

This site was available on the date of the last automated link check. (2025/09/01)

image
IdentifierURL:https://episphere.github.io/serohub/
Typedata set
Biological Scalepopulation
Collection End Date
LanguageEnglish
Topics
  • Disease
    • Infectious Disease
      • Vaccine-Preventable Disease
        • COVID-19
      • Viruses Infection
        • Viral Respiratory Tract Infection
          • COVID-19
  • Host
    • Homo sapiens
  • Immunology
  • Pathogen
    • Viruses
      • SARS-CoV2
  • Population Demographic
    • Age-Stratified
    • Ethnicity
    • Race
    • Sex
Geographical ScopeUnited States
Geographical ResolutionState
Start Date2020/03/01
End Date
Versionunspecified
Accessible For FreeTRUE
Licenseunspecified
Rightshttps://www.cancer.gov/policies/disclaimer
HTTP Status Code200
HTTP Checked On2025/09/01